(Q37616946)

English

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.

scientific article published on 25 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2. (English)

1 reference

Europe PubMed Central

21 August 2017

arterial hypertension

0 references

connective tissue

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

connective tissue disease

1 reference

based on heuristic

inferred from title

Gabriela Riemekasten

6

object named as

Gabriela Riemekasten

1 reference

Europe PubMed Central

21 August 2017

Carmine Dario Vizza

object named as

Carmine Dario Vizza

7

0 references

Friedrich Grimminger

object named as

Friedrich Grimminger

4

0 references

object named as

Marc Humbert

1

0 references

author name string

J Gerry Coghlan

2

1 reference

Europe PubMed Central

21 August 2017

Hossein-Ardeschir Ghofrani

3

1 reference

Europe PubMed Central

21 August 2017

Jian-Guo He

5

1 reference

Europe PubMed Central

21 August 2017

Annette Boeckenhoff

8

1 reference

Europe PubMed Central

21 August 2017

Christian Meier

9

1 reference

Europe PubMed Central

21 August 2017

Janethe de Oliveira Pena

10

1 reference

Europe PubMed Central

21 August 2017

Christopher P Denton

11

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

25 July 2016

1 reference

Europe PubMed Central

21 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

21 August 2017

76

1 reference

Europe PubMed Central

21 August 2017

2

1 reference

Europe PubMed Central

21 August 2017

422-426

1 reference

Europe PubMed Central

21 August 2017

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Riociguat for the treatment of pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Pulmonary arterial hypertension in connective tissue diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

23 August 2017

Soluble guanylate cyclase stimulators in pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

6 September 2017

Mechanisms of disease: pulmonary arterial hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

6 September 2017

Riociguat for the treatment of pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

6 September 2017

Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

28 September 2017

Sildenafil for pulmonary arterial hypertension associated with connective tissue disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

25 June 2018

Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

1 September 2018

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5284330

1 September 2018

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-209087

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2015-209087

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37616946&oldid=1525527316"